[miR-497 suppresses proliferation of human cervical carcinoma HeLa cells by targeting cyclin E1]

Jiming Han1, Manpeng Huo1, Mingtao Mu1

  • 1Medical College, Yan'an University, Yan'an 716000, China.

Abstract

Insights

MicroRNA-497 (miR-497) significantly inhibits human cervical carcinoma HeLa cell proliferation. This microRNA targets cyclin E1 (CCNE1), suppressing its expression and impacting cancer cell growth.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Context:

  • Cervical carcinoma is a significant global health concern.
  • Understanding the molecular mechanisms underlying cervical cancer progression is crucial for developing targeted therapies.
  • MicroRNAs play critical roles in regulating gene expression and are implicated in various cancers.

Purpose:

  • To investigate the role of miR-497 in the proliferation of human cervical carcinoma HeLa cells.
  • To determine the direct target relationship between miR-497 and cyclin E1 (CCNE1).

Summary:

  • The study successfully constructed recombinant plasmids to overexpress miR-497 in HeLa cells.
  • MTT assays demonstrated that elevated miR-497 levels significantly inhibit HeLa cell proliferation.
  • Dual-luciferase reporter assays, qRT-PCR, and Western blotting confirmed that miR-497 directly targets CCNE1, downregulating its mRNA and protein expression.

Impact:

  • This research elucidates a novel regulatory pathway in cervical cancer involving miR-497 and CCNE1.
  • The findings suggest that miR-497 could be a potential therapeutic agent for cervical carcinoma.
  • Targeting the miR-497/CCNE1 axis may offer a new strategy for cervical cancer treatment.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
3.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K